{"id":32630,"date":"2022-04-15T15:46:15","date_gmt":"2022-04-15T13:46:15","guid":{"rendered":"https:\/\/www.unither-pharma.com\/?post_type=publication&#038;p=32630"},"modified":"2026-04-15T15:47:01","modified_gmt":"2026-04-15T13:47:01","slug":"quest-ce-quun-medicament-orphelin","status":"publish","type":"publication","link":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/","title":{"rendered":"Qu&rsquo;est-ce qu&rsquo;un m\u00e9dicament orphelin ?"},"content":{"rendered":"\r\n\r\nLe <strong>m\u00e9dicament orphelin<\/strong> est le traitement prescrit \u00e0 une personne atteinte d&rsquo;une maladie rare. Une loi a \u00e9t\u00e9 instaur\u00e9e par l&rsquo;Union europ\u00e9enne dans l&rsquo;optique d&rsquo;inciter l&rsquo;industrie pharmaceutique et les soci\u00e9t\u00e9s de biotechnologie \u00e0 d\u00e9velopper ce genre de m\u00e9dicament afin que les personnes atteintes d&rsquo;affections rares puissent b\u00e9n\u00e9ficier de traitement de qualit\u00e9.\r\n\r\n\r\n<h2 class=\"wp-block-heading\">Affections rares<\/h2>\r\n\r\n\r\nUne affection rare affecte moins de 30 000 personnes. Cela signifie que le d\u00e9veloppement et la mise sur le march\u00e9 d&rsquo;un m\u00e9dicament orphelin ne peuvent \u00eatre rentabilis\u00e9s par les ventes de ce traitement. Dans ce contexte, il est tr\u00e8s compliqu\u00e9 pour les entreprises pharmaceutiques d&rsquo;\u00eatre motiv\u00e9es \u00e0 investir dans le d\u00e9veloppement d&rsquo;un traitement qui permettrait de <strong>diagnostiquer et pr\u00e9venir des maladies orphelines <\/strong>sous les conditions de commercialisation en vigueur. Cependant, il est incontestable que les personnes atteintes de telles affections doivent pouvoir obtenir des traitements de qualit\u00e9 au m\u00eame niveau que les autres malades. C&rsquo;est pour cela qu&rsquo;il a \u00e9t\u00e9 d\u00e9cid\u00e9 d&rsquo;encourager l&rsquo;industrie pharmaceutique \u00e0 rechercher, d\u00e9velopper et commercialiser des traitements adapt\u00e9s.\r\n\r\n\r\n\r\nChez <strong>Unither Pharmaceuticals<\/strong>, nous fabriquons et conditionnons des lots commerciaux de m\u00e9dicaments orphelins.\r\n\r\n\r\n\r\nGr\u00e2ce \u00e0 un large panel de produits et \u00e0 des comp\u00e9tences alliant innovation et d\u00e9veloppement, nous cr\u00e9ons des formes gal\u00e9niques pour une large <strong>diversit\u00e9 de traitements<\/strong>. Cette comp\u00e9tence nous permet de d\u00e9velopper des formulations de produits pharmaceutiques visant les maladies orphelines. Notre exp\u00e9rience dans la fabrication de m\u00e9dicaments orphelins est gage de qualit\u00e9 et de s\u00e9curit\u00e9.\r\n\r\n\r\n<h2 class=\"wp-block-heading\">L&rsquo;acc\u00e8s \u00e0 tous<\/h2>\r\n\r\n\r\nIl est impensable d&rsquo;envisager que des patients atteints de maladies orphelines soient dans l&rsquo;incapacit\u00e9 d&rsquo;avoir acc\u00e8s \u00e0 des traitements adapt\u00e9s \u00e0 leur pathologie. Ils ont droit aux soins au m\u00eame titre que tout autre patient. Plusieurs mesures mises en place par les pouvoirs publics encouragent<strong> les industriels de la sant\u00e9 et des biotechnologies<\/strong> \u00e0 pers\u00e9v\u00e9rer dans la recherche et le d\u00e9veloppement des m\u00e9dicaments orphelins. La principale mission d&rsquo;Unither Pharmaceuticals est d&rsquo;\u00e9laborer des traitements innovants, durables et comp\u00e9titifs adapt\u00e9s aux besoins des patients afin qu&rsquo;ils soient commercialis\u00e9s par nos clients industriels pharmaceutiques.\r\n\r\n\r\n\r\nNotre objectif est de proposer des produits de sant\u00e9 accessibles \u00e0 tous et simples d&rsquo;utilisation afin de faciliter l&rsquo;existence des patients atteints de maladies orphelines dans le monde entier. Notre technologie adapt\u00e9e ainsi que l&rsquo;implication de nos \u00e9quipes lors de congr\u00e8s scientifiques, nous permettent de pr\u00e9senter r\u00e9guli\u00e8rement des innovations aux industries pharmaceutiques. Dans l&rsquo;unique but d&rsquo;apporter un confort certain aux patients, nous proposons, via nos plateformes technologiques, des formulations innovantes non-brevet\u00e9es ainsi que divers syst\u00e8mes d&rsquo;administration de <strong>traitements brevet\u00e9s<\/strong>.\r\n\r\n\r\n<h2 class=\"wp-block-heading\">L\u2019innovation au service des patients<\/h2>\r\n\r\n\r\nParce que la <strong>sant\u00e9<\/strong> est une priorit\u00e9 et que tout le monde a \u00a0le droit d&rsquo;acc\u00e9der \u00e0 des soins quelle que soit la pathologie rencontr\u00e9e, nous sommes totalement engag\u00e9s dans la recherche et l&rsquo;\u00e9laboration de nouveaux traitements permettant d&rsquo;am\u00e9liorer la vie des patients. Nos principales valeurs sont le respect de nos collaborateurs et, bien \u00e9videmment, la satisfaction de nos clients. Les relations construites avec nos partenaires sont bas\u00e9es sur une confiance mutuelle.\r\n\r\n\r\n\r\nFace \u00e0 de nouveaux d\u00e9fis, l&rsquo;\u00e9quipe d&rsquo;Unither Pharmaceuticals vous apporte de nouvelles solutions.\r\n\r\n","protected":false},"excerpt":{"rendered":"<p>Le m\u00e9dicament orphelin est le traitement prescrit \u00e0 une personne atteinte d&rsquo;une maladie rare. Une loi a \u00e9t\u00e9 instaur\u00e9e par l&rsquo;Union europ\u00e9enne dans l&rsquo;optique d&rsquo;inciter l&rsquo;industrie pharmaceutique et les soci\u00e9t\u00e9s de biotechnologie \u00e0 d\u00e9velopper ce genre de m\u00e9dicament afin que les personnes atteintes d&rsquo;affections rares puissent b\u00e9n\u00e9ficier de traitement de qualit\u00e9. Affections rares Une affection [&hellip;]<\/p>\n","protected":false},"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false},"topic":[],"media_type":[189],"class_list":["post-32630","publication","type-publication","status-publish","hentry","media_type-article"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Qu&#039;est-ce qu&#039;un m\u00e9dicament orphelin ? | Unither<\/title>\n<meta name=\"description\" content=\"Qu&#039;est-ce qu&#039;un m\u00e9dicament orphelin ? | Unither\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qu&#039;est-ce qu&#039;un m\u00e9dicament orphelin ? | Unither\" \/>\n<meta property=\"og:description\" content=\"Qu&#039;est-ce qu&#039;un m\u00e9dicament orphelin ? | Unither\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/\" \/>\n<meta property=\"og:site_name\" content=\"Unither\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-15T13:47:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/\",\"name\":\"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\"},\"datePublished\":\"2022-04-15T13:46:15+00:00\",\"dateModified\":\"2026-04-15T13:47:01+00:00\",\"description\":\"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unither-pharma.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qu&rsquo;est-ce qu&rsquo;un m\u00e9dicament orphelin ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"name\":\"Unither\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\",\"name\":\"Unither\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"width\":514,\"height\":252,\"caption\":\"Unither\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/UnitherPharma\",\"https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/\",\"https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither","description":"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/","og_locale":"fr_FR","og_type":"article","og_title":"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither","og_description":"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither","og_url":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/","og_site_name":"Unither","article_modified_time":"2026-04-15T13:47:01+00:00","twitter_card":"summary_large_image","twitter_site":"@UnitherPharma","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/","url":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/","name":"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#website"},"datePublished":"2022-04-15T13:46:15+00:00","dateModified":"2026-04-15T13:47:01+00:00","description":"Qu'est-ce qu'un m\u00e9dicament orphelin ? | Unither","breadcrumb":{"@id":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.unither-pharma.com\/fr\/publication\/quest-ce-quun-medicament-orphelin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unither-pharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Qu&rsquo;est-ce qu&rsquo;un m\u00e9dicament orphelin ?"}]},{"@type":"WebSite","@id":"https:\/\/www.unither-pharma.com\/fr\/#website","url":"https:\/\/www.unither-pharma.com\/fr\/","name":"Unither","description":"","publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.unither-pharma.com\/fr\/#organization","name":"Unither","url":"https:\/\/www.unither-pharma.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","width":514,"height":252,"caption":"Unither"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/UnitherPharma","https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/","https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA"]}]}},"_links":{"self":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/publication\/32630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=32630"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/topic?post=32630"},{"taxonomy":"media_type","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media_type?post=32630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}